HDT Bio is a clinical stage private company developing advanced products to treat and prevent cancer and infectious diseases. Utilizing our proprietary LION™ technology, our products feature superior safety, potency, durability, and manufacturing advantages.
HDT Bio is a clinical stage private company developing advanced products to treat and prevent cancer and infectious diseases. Utilizing our proprietary LION™ technology, our products feature superior safety, potency, durability, and manufacturing advantages
HDT Bio is a clinical stage private company developing advanced products to treat and prevent cancer and infectious diseases. Utilizing our proprietary LION™ technology, our products feature superior safety, potency, durability, and manufacturing advantages
HDT Bio’s proprietary technologies harness the immune system to combat difficult-to-treat conditions and improve patient lives worldwide.
The next generation of formulations
HDT’s LION™ technology provides increased potency compared to traditional formulations – increasing safety, tolerability, immunogenicity, and manufacturability.
Latest News
Providence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
Click here to view article